Various types of nanoparticles with their beneficial attributes and limitations
|Types of nanoparticles||Beneficial attributes||Limitations||References|
||Lack of long circulating as drug carriers||[91, 92]|
|FA combined with PEG||Enhances FA receptor mediated targeting delivery||
|PLA nanoparticles||Sustained drug release period, biodegradable & biocompatible||
The authors acknowledge Jaypee Institute of Information Technology, Noida, for providing the entire infrastructure to complete this project.
M Singh and DJ contributed in conceptualization, design of the work, resourcing, interpretation of data. M Singh, DJ, VA, DP, M Sharma, and PP contributed to writing—original draft, and writing—review & editing; M Singh, SM, and R contributed in supervision; M Singh, DJ, SM and R contributed in data curation, and validation.
The authors declare that they have no conflicts of interest.
© The Author(s) 2022.